NRD
TWST icon

Nebula Research & Development’s Twist Bioscience TWST Stock Holding History

Nebula Research & Development’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,905
Closed -$735K – 1173
2024
Q2 		$735K Buy
+14,905
New +$608K 0.12% 310

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nebula Research & Development's TWST Position: Q3 2024 in Review

Nebula Research & Development sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 14,905 shares — an estimated $735K sold.

Nebula Research & Development first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $735K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Nebula Research & Development reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Nebula Research & Development sold 14,905 Twist Bioscience shares in Q3 2024, an estimated $735K.
  • Nebula Research & Development first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • Nebula Research & Development's Twist Bioscience position peaked at $735K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.